The Genome and Biomarker Sciences (GBx) unit advances targets rooted in human genetics and genomics. We invest in innovative genomic and biomarker technologies for maximal pipeline impact. We leverage disease-relevant tissue samples to identify and apply genomic and protein biomarkers to inform clinical decision-making and exploratory research. Our goal is to translate the best human genetic targets into actionable biology.